Cargando…

Is GH Replacement for Adult GH Deficiency Safe?

Detalles Bibliográficos
Autor principal:	Melmed, Shlomo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516130/ https://www.ncbi.nlm.nih.gov/pubmed/35552733 http://dx.doi.org/10.1210/clinem/dgac307

Ejemplares similares

Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial
por: Sävendahl, Lars, et al.
Publicado: (2020)

GH and Senescence: A New Understanding of Adult GH Action
por: Chesnokova, Vera, et al.
Publicado: (2021)

Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial
por: Johannsson, Gudmundur, et al.
Publicado: (2020)

Response to GH Treatment After Radiation Therapy Depends on Location of Irradiation
por: Rose, Susan R, et al.
Publicado: (2020)

Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients
por: Hartman, Mark L., et al.
Publicado: (2013)

Metabolomics: a tool for the diagnosis of GH deficiency and for monitoring GH replacement?
por: Höybye, Charlotte, et al.
Publicado: (2014)

Impact of Growth Hormone (GH) Deficiency and GH Replacement upon Thymus Function in Adult Patients
por: Morrhaye, Gabriel, et al.
Publicado: (2009)

CORRIGENDUM for “Treatment of Children With GH in the United States and Europe: Long-Term Follow-Up From NordiNet® IOS and ANSWER Program”
Publicado: (2020)

Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency
por: Elbornsson, Mariam, et al.
Publicado: (2012)

A Case With Adult GH Deficiency Complicated With Osteogenesis Imperfecta: Effect of GH Replacement on Bone Mineral Density
por: Taguchi, Tomomi, et al.
Publicado: (2021)

GH Is a Component of SASP in Aging Tissue
por: Chesnokova, Vera M, et al.
Publicado: (2021)

Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency
por: Elbornsson, Mariam, et al.
Publicado: (2012)

Favorable Impacts of Growth Hormone (GH) Replacement Therapy on Atherogenic Risks in Japanese Children with GH Deficiency
por: Kohno, Hitoshi, et al.
Publicado: (2012)

GH deficiency status combined with GH receptor polymorphism affects response to GH in children
por: Valsesia, Armand, et al.
Publicado: (2015)

Diagnosis of GH Deficiency Without GH Stimulation Tests
por: Ibba, Anastasia, et al.
Publicado: (2022)

GH deficiency in patients with spinal cord injury: efficacy/safety of GH replacement, a pilot study
por: Cuatrecasas, Guillem, et al.
Publicado: (2018)

GH deficiency and insensitivity in children and adults
por: Johannsson, Gudmundur, et al.
Publicado: (2021)

Three-Year Follow-up Study on Serum Leptin Levels in GH Deficient Children with GH Replacement Therapy
por: Kishi, Megumi, et al.
Publicado: (2006)

GH Replacement in the Elderly: Is It Worth It?
por: Ricci Bitti, Silvia, et al.
Publicado: (2021)

Childhood-Onset GH Deficiency versus Adult-Onset GH Deficiency: Relevant Differences Regarding Insulin Sensitivity
por: Garmes, Heraldo Mendes, et al.
Publicado: (2022)

No Improvement of Adult Height in Non-growth Hormone (GH) Deficient Short Children with GH Treatment
por: Tanaka, Toshiaki, et al.
Publicado: (2006)

Thyroid function in children with growth hormone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications
por: Smyczynska, Joanna, et al.
Publicado: (2010)

Prevalence of growth hormone (GH) deficiency in previously GH‐treated young adults with Prader‐Willi syndrome
por: Donze, Stephany H., et al.
Publicado: (2019)

Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease
por: Araki, Takako, et al.
Publicado: (2021)

Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS)
por: Mo, Daojun, et al.
Publicado: (2013)

Atypical Course of a Patient With AIP-Positive Acromegaly: From GH Excess to GH Deficiency and Back to GH Excess
por: García-de-la-Torre, Keren-Sandyn, et al.
Publicado: (2023)

OR16-06 Age-Associated Local GH Promotes Colon Neoplasia
por: Chesnokova, Vera M, et al.
Publicado: (2020)

GH Supplementation Effects on Cardiovascular Risk in GH Deficient Adult Patients: A Systematic Review and Meta-analysis
por: Giagulli, Vito A., et al.
Publicado: (2017)

Growth Hormone (GH) Treatment Decreases Plasma Kisspeptin Levels in GH-Deficient Adults with Prader–Willi Syndrome
por: Giménez-Palop, Olga, et al.
Publicado: (2021)

Diagnosis of growth hormone (GH) deficiency: comparison of pituitary stalk interruption syndrome and transient GH deficiency
por: Louvel, Murielle, et al.
Publicado: (2009)

Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index: a precursor to cost–utility analysis
por: Kołtowska-Häggström, Maria, et al.
Publicado: (2008)

Regulation of GH and GH Signaling by Nutrients
por: Caputo, Marina, et al.
Publicado: (2021)

SAT642 Effective Gh Replacement With Once-weekly Somapacitan In Children With Gh Deficiency: 2-year Results From Real4
por: Miller, Bradley Scott, et al.
Publicado: (2023)

THU045 WIP1 Phosphatase Is A Novel Specific Target For Epithelial GH Action
por: Apaydin, Tugce, et al.
Publicado: (2023)

Accuracy and Limitations of the Growth Hormone (GH) Releasing Hormone-Arginine Retesting in Young Adults With Childhood-Onset GH Deficiency
por: Patti, Giuseppa, et al.
Publicado: (2019)

Increased Secretion of Endogenous GH after Treatment with an Intranasal GH-releasing Peptide-2 Spray Does Not Promote Growth in Short Children with GH Deficiency
por: Tanaka, Toshiaki, et al.
Publicado: (2014)

IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction
por: Joustra, Sjoerd D, et al.
Publicado: (2019)

Effects of recombinant growth hormone (GH) replacement and psychomotor and cognitive stimulation in the neurodevelopment of GH-deficient (GHD) children with cerebral palsy: a pilot study
por: Devesa, Jesús, et al.
Publicado: (2011)

MON-459 ONO-5788, a Novel Oral Small Molecule Somatostatin Receptor Type-2 (SST2) Agonist, Attenuates GH Hypersecretion in Human GH-Secreting, Pituitary Adenoma-Derived Cells
por: Zhou, Cuiqi, et al.
Publicado: (2019)

Therapeutic Efficacy and Safety of GH in Japanese Children with Down Syndrome Short Stature Accompanied by GH Deficiency
por: Meguri, Kyoko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dafrkddi1ughijh24t0dhnab0e